CreditReports.dk
HomeScreen companies

MISSIONPHARMA GROUP ApS Financials, key figures and credit report

CVR number: 29782792 Established 2006 Industry: 64.2020 Activities of holding companies
Company contact details
Vassingerødvej 9, 3540 Lynge
Net sales 924.3 mDKK FY 2022 +35.4% vs 2021
EBIT margin 17.3 % FY 2022 +7.2 pp vs 2021
Net debt -25.0 mDKK FY 2022 +17.7% vs 2021
Quick ratio 4.1 FY 2022 +0.6 vs 2021

Income statement (mDKK)

2018
2019
2020
2021
2022
Fiscal period length1212121212
Net sales756.97780.35726.93682.48924.32
Change in finished goods inventory- 486.84- 429.91
Purchases during the financial year- 461.64
Costs of manufacturing- 384.92- 571.60
External services- 174.75- 194.26- 114.78- 164.06- 123.38
Gross profit120.5899.25182.24133.50229.34
Employee benefit expenses-58.04-55.50-57.65-55.64-65.44
Total depreciation-12.09-11.85-9.12-8.84-4.30
EBIT50.4531.90115.4669.02159.60
Other financial income3.683.601.331.503.93
Other financial expenses-10.00-10.99-14.88-1.23-9.13
Pre-tax profit44.1324.51101.9269.29154.40
Income taxes-11.21-7.52-23.85-16.98-35.14
Net earnings32.9216.9878.0752.30119.26

Assets (mDKK)

2018
2019
2020
2021
2022
Development expenditure2.140.44
Intangible rights3.970.31
Goodwill21.0814.688.271.87
Intangible assets total27.1914.988.271.870.44
Land and waters27.0725.6825.4924.2924.90
Buildings3.082.402.404.82
Machinery and equipment6.22
Other tangible assets1.321.3819.5518.42
Tangible assets total34.6230.1327.9046.2448.14
Other non-current investments-1.9620.0019.17
Investments total-1.9620.0019.17
Non-current loans receivable17.57
Long term receivables total17.57
Finished products/goods109.9377.5097.9298.95111.48
Inventories total109.9377.5097.9298.95111.48
Current trade debtors224.83182.26148.4855.2762.23
Current amounts owed by group member comp.95.71162.30212.39
Prepayments and accrued income1.871.043.5625.9273.61
Current other receivables-23.9921.4615.5710.254.56
Current deferred tax assets13.645.891.0911.0112.26
Short term receivables total216.35210.66264.41264.74365.05
Cash and bank deposits21.1954.3337.2130.4325.04
Cash and cash equivalents21.1954.3337.2130.4325.04
Balance sheet total (assets)424.88407.60454.88442.23550.15

Equity and liabilities (mDKK)

2018
2019
2020
2021
2022
Share capital0.130.130.130.130.13
Shares repurchased26.3013.5078.0090.00150.00
Other reserves-1.39- 323.88- 352.06
Other restricted equity322.93349.72
Retained earnings237.52254.15193.37181.4582.68
Profit of the financial year32.9216.9878.0752.30119.26
Minority interest (BS)0.290.290.250.321.35
Shareholders equity total297.15285.06348.43323.25351.07
Provisions2.873.122.87
Non-current other liabilities13.60
Non-current deferred tax liabilities1.350.02
Non-current liabilities total13.601.350.02
Current loans from credit institutions52.640.070.08
Advances received20.9336.7219.6933.92104.28
Current trade creditors31.5662.4357.5655.9856.61
Short-term deferred tax liabilities0.920.200.56
Other non-interest bearing current liabilities18.8120.0025.7027.7338.16
Current liabilities total124.86119.42103.58117.63199.06
Balance sheet total (liabilities)438.49407.60454.88442.23550.15
Page generated